Baker John E, Su Jidong, Fu Xiangping, Hsu Anna, Gross Garrett J, Tweddell James S, Hogg Neil
Division of Cardiothoracic Surgery, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
J Mol Cell Cardiol. 2007 Oct;43(4):437-44. doi: 10.1016/j.yjmcc.2007.07.057. Epub 2007 Jul 31.
Reduction of nitrite to nitric oxide during ischemia protects the heart against injury from ischemia/reperfusion. However the optimal dose of nitrite and the mechanisms underlying nitrite-induced cardioprotection are not known. We determined the ability of nitrite and nitrate to confer protection against myocardial infarction in two rat models of ischemia/reperfusion injury and the role of xanthine oxidoreductase, NADPH oxidase, nitric oxide synthase and K(ATP) channels in mediating nitrite-induced cardioprotection. In vivo and in vitro rat models of myocardial ischemia/reperfusion injury were used to cause infarction. Hearts (n=6/group) were treated with nitrite or nitrate for 15 min prior to 30 min regional ischemia and 180 min reperfusion. Xanthine oxidoreductase activity was measured after 15 min aerobic perfusion and 30 min ischemia. Nitrite reduced myocardial necrosis and decline in ventricular function following ischemia/reperfusion in the intact and isolated rat heart in a dose- or concentration-dependent manner with an optimal dose of 4 mg/kg in vivo and concentration of 10 microM in vitro. Nitrate had no effect on protection. Reduction in infarction by nitrite was abolished by the inhibition of flavoprotein reductases and the molybdenum site of xanthine oxidoreductase and was associated with an increase in activity of xanthine dehydrogenase and xanthine oxidase during ischemia. Inhibition of nitric oxide synthase had no effect on nitrite-induced cardioprotection. Inhibition of NADPH oxidase and K(ATP) channels abolished nitrite-induced cardioprotection. Nitrite but not nitrate protects against infarction by a mechanism involving xanthine oxidoreductase, NADPH oxidase and K(ATP) channels.
缺血期间亚硝酸盐还原为一氧化氮可保护心脏免受缺血/再灌注损伤。然而,亚硝酸盐的最佳剂量以及亚硝酸盐诱导心脏保护作用的潜在机制尚不清楚。我们在两种缺血/再灌注损伤大鼠模型中确定了亚硝酸盐和硝酸盐赋予心肌梗死保护作用的能力,以及黄嘌呤氧化还原酶、NADPH氧化酶、一氧化氮合酶和K(ATP)通道在介导亚硝酸盐诱导的心脏保护作用中的作用。采用体内和体外大鼠心肌缺血/再灌注损伤模型诱导梗死。在30分钟局部缺血和180分钟再灌注前15分钟,用亚硝酸盐或硝酸盐处理心脏(每组n = 6)。在有氧灌注15分钟和缺血30分钟后测量黄嘌呤氧化还原酶活性。亚硝酸盐以剂量或浓度依赖性方式减少完整和离体大鼠心脏缺血/再灌注后的心肌坏死和心室功能下降,体内最佳剂量为4 mg/kg,体外浓度为10 μM。硝酸盐对保护作用无影响。抑制黄素蛋白还原酶和黄嘌呤氧化还原酶的钼位点可消除亚硝酸盐对梗死的减少作用,且这与缺血期间黄嘌呤脱氢酶和黄嘌呤氧化酶活性增加有关。抑制一氧化氮合酶对亚硝酸盐诱导的心脏保护作用无影响。抑制NADPH氧化酶和K(ATP)通道可消除亚硝酸盐诱导的心脏保护作用。亚硝酸盐而非硝酸盐通过涉及黄嘌呤氧化还原酶、NADPH氧化酶和K(ATP)通道的机制预防梗死。